Insmed, Inc. (INSM): Price and Financial Metrics

INSM POWR Grades

• Sentiment is the dimension where INSM ranks best; there it ranks ahead of 81.97% of US stocks.
• The strongest trend for INSM is in Stability, which has been heading down over the past 177 days.
• INSM ranks lowest in Momentum; there it ranks in the 3rd percentile.

INSM Stock Summary

• INSMED INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 91.26% of US listed stocks.
• Of note is the ratio of INSMED INC's sales and general administrative expense to its total operating expenses; only 22.03% of US stocks have a lower such ratio.
• INSM's price/sales ratio is 11.37; that's higher than the P/S ratio of 90.73% of US stocks.
• Stocks that are quantitatively similar to INSM, based on their financial statements, market capitalization, and price volatility, are CYTK, FBIO, TVTX, MREO, and PXLW.
• Visit INSM's SEC page to see the company's official filings. To visit the company's web site, go to www.insmed.com.

INSM Valuation Summary

• INSM's price/sales ratio is 11.7; this is 151.61% higher than that of the median Healthcare stock.
• Over the past 243 months, INSM's EV/EBIT ratio has gone down 8.4.

Below are key valuation metrics over time for INSM.

INSM Growth Metrics

Its 3 year net cashflow from operations growth rate is now at -28.96%.
• Its 2 year net income to common stockholders growth rate is now at -77.5%.
• The 3 year revenue growth rate now stands at 534.45%.

Over the past 33 months, INSM's revenue has gone up $120,615,000.

The table below shows INSM's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	221.209	-367.039	-415.958
2022-03-31	201.354	-340.182	-437.634
2021-12-31	188.461	-363.302	-434.654
2021-09-30	173.752	-345.962	-423.889
2021-06-30	170.638	-329.185	-374.834
2021-03-31	167.767	-289.694	-319.367

INSM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• INSM has a Quality Grade of C, ranking ahead of 31.6% of graded US stocks.
• INSM's asset turnover comes in at 0.172 -- ranking 207th of 682 Pharmaceutical Products stocks.
• CYRX, CTLT, and ACOR are the stocks whose asset turnover ratios are most correlated with INSM.

The table below shows INSM's key quality metrics over time.